718 related articles for article (PubMed ID: 21622540)
21. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
Hoogenraad TU
Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
[TBL] [Abstract][Full Text] [Related]
22. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
[TBL] [Abstract][Full Text] [Related]
23. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
Sinha S; Taly AB
J Neurol Sci; 2008 Jan; 264(1-2):129-32. PubMed ID: 17765927
[TBL] [Abstract][Full Text] [Related]
24. [True hepatic Wilson's disease].
Ciravegna B; Giacchino R; Marazzi MG
Pediatr Med Chir; 1983; 5(1-2):7-10. PubMed ID: 6634446
[TBL] [Abstract][Full Text] [Related]
25. Ocular manifestations of Wilson's disease in Iran.
Kashani AA
Trans Ophthalmol Soc U K (1962); 1977 Apr; 97(1):18-9. PubMed ID: 271391
[TBL] [Abstract][Full Text] [Related]
26. Wilson's disease with hepatic presentation in childhood.
Karim MB; Rahman MM; Islam MS
Mymensingh Med J; 2007 Jan; 16(1):29-32. PubMed ID: 17344776
[TBL] [Abstract][Full Text] [Related]
27. Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine, 2HCl): long-term observations.
Morita J; Yoshino M; Watari H; Yoshida I; Motohiro T; Yamashita F; Okano Y; Hashimoto T
Dev Pharmacol Ther; 1992; 19(1):6-9. PubMed ID: 1307347
[TBL] [Abstract][Full Text] [Related]
28. Iron accumulation in the liver of male patients with Wilson's disease.
Shiono Y; Wakusawa S; Hayashi H; Takikawa T; Yano M; Okada T; Mabuchi H; Kono S; Miyajima H
Am J Gastroenterol; 2001 Nov; 96(11):3147-51. PubMed ID: 11721763
[TBL] [Abstract][Full Text] [Related]
29. Urinary excretion of copper, zinc and iron with and without D-penicillamine administration in relation to hepatic copper concentration in dogs.
Fieten H; Hugen S; van den Ingh TS; Hendriks WH; Vernooij JC; Bode P; Watson AL; Leegwater PA; Rothuizen J
Vet J; 2013 Aug; 197(2):468-73. PubMed ID: 23583003
[TBL] [Abstract][Full Text] [Related]
30. Urinary copper excretion and hepatic copper concentrations in liver disease.
Frommer DJ
Digestion; 1981; 21(4):169-78. PubMed ID: 7215719
[TBL] [Abstract][Full Text] [Related]
31. Wilson's disease: assessment of D-penicillamine treatment.
Van Caillie-Bertrand M; Degenhart HJ; Luijendijk I; Bouquet J; Sinaasappel M
Arch Dis Child; 1985 Jul; 60(7):652-5. PubMed ID: 4026361
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of oral chelators in treatment of patients with Wilson disease.
Weiss KH; Thurik F; Gotthardt DN; Schäfer M; Teufel U; Wiegand F; Merle U; Ferenci-Foerster D; Maieron A; Stauber R; Zoller H; Schmidt HH; Reuner U; Hefter H; Trocello JM; Houwen RH; Ferenci P; Stremmel W;
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):1028-35.e1-2. PubMed ID: 23542331
[TBL] [Abstract][Full Text] [Related]
33. Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson's disease in children.
Müller T; Koppikar S; Taylor RM; Carragher F; Schlenck B; Heinz-Erian P; Kronenberg F; Ferenci P; Tanner S; Siebert U; Staudinger R; Mieli-Vergani G; Dhawan A
J Hepatol; 2007 Aug; 47(2):270-6. PubMed ID: 17449133
[TBL] [Abstract][Full Text] [Related]
34. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study.
Merle U; Schaefer M; Ferenci P; Stremmel W
Gut; 2007 Jan; 56(1):115-20. PubMed ID: 16709660
[TBL] [Abstract][Full Text] [Related]
35. Compliant treatment with anti-copper agents prevents clinically overt Wilson's disease in pre-symptomatic patients.
Dzieżyc K; Karliński M; Litwin T; Członkowska A
Eur J Neurol; 2014 Feb; 21(2):332-7. PubMed ID: 24313946
[TBL] [Abstract][Full Text] [Related]
36. Wilson's disease.
Loudianos G; Gitlin JD
Semin Liver Dis; 2000; 20(3):353-64. PubMed ID: 11076401
[TBL] [Abstract][Full Text] [Related]
37. [Effects of the combined administration of glutathione and D-penicillamine on the urinary copper excretion in Wilson's disease].
Atsuba Y; Nakahachi T; Terai T; Kozakai T
No To Shinkei; 1968 Feb; 20(2):187-95. PubMed ID: 5695072
[No Abstract] [Full Text] [Related]
38. [Wilson's disease].
Kovacević I; Zekan M
Acta Med Croatica; 2003; 57(3):227-35. PubMed ID: 14582469
[TBL] [Abstract][Full Text] [Related]
39. Serum 'free' copper in Wilson disease.
Walshe JM
QJM; 2012 May; 105(5):419-23. PubMed ID: 22139498
[TBL] [Abstract][Full Text] [Related]
40. Contribution to the data on copper concentration in blood and urine in patients with Wilson's disease and in normal subjects.
Lech T; Sadlik JK
Biol Trace Elem Res; 2007 Jul; 118(1):16-20. PubMed ID: 17848726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
